A detailed history of Wellington Management Group LLP transactions in United Therapeutics Corp stock. As of the latest transaction made, Wellington Management Group LLP holds 3,170,849 shares of UTHR stock, worth $1.15 Billion. This represents 0.2% of its overall portfolio holdings.

Number of Shares
3,170,849
Previous 3,285,289 3.48%
Holding current value
$1.15 Billion
Previous $1.05 Billion 8.58%
% of portfolio
0.2%
Previous 0.19%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$311.04 - $363.55 $35.6 Million - $41.6 Million
-114,440 Reduced 3.48%
3,170,849 $1.14 Billion
Q2 2024

Aug 13, 2024

SELL
$228.26 - $319.04 $29 Million - $40.5 Million
-126,971 Reduced 3.72%
3,285,289 $1.05 Billion
Q1 2024

May 15, 2024

BUY
$210.76 - $249.51 $719 Million - $851 Million
3,412,260 New
3,412,260 $784 Million
Q4 2023

Feb 12, 2024

BUY
$214.88 - $256.94 $815 Million - $975 Million
3,794,010 New
3,794,010 $834 Million
Q3 2023

Nov 14, 2023

SELL
$211.82 - $248.24 $120 Million - $141 Million
-567,011 Reduced 12.09%
4,121,813 $931 Million
Q2 2023

Aug 14, 2023

BUY
$205.19 - $232.99 $186 Million - $211 Million
906,984 Added 23.98%
4,688,824 $1.04 Billion
Q1 2023

May 12, 2023

BUY
$212.99 - $276.17 $258 Million - $335 Million
1,212,577 Added 47.2%
3,781,840 $847 Million
Q4 2022

Feb 13, 2023

BUY
$205.95 - $280.43 $250 Million - $340 Million
1,212,497 Added 89.37%
2,569,263 $714 Million
Q3 2022

Nov 14, 2022

SELL
$203.3 - $244.17 $19.8 Million - $23.8 Million
-97,291 Reduced 6.69%
1,356,766 $284 Million
Q2 2022

Aug 15, 2022

SELL
$174.81 - $241.14 $38.7 Million - $53.4 Million
-221,357 Reduced 13.21%
1,454,057 $343 Million
Q1 2022

May 16, 2022

BUY
$166.16 - $213.96 $118 Million - $152 Million
710,668 Added 73.66%
1,675,414 $301 Million
Q4 2021

Feb 11, 2022

BUY
$184.32 - $216.08 $177 Million - $208 Million
962,136 Added 36863.45%
964,746 $208 Million
Q3 2021

Nov 15, 2021

BUY
$179.86 - $214.88 $166,190 - $198,549
924 Added 54.8%
2,610 $482,000
Q2 2021

Aug 16, 2021

BUY
$170.47 - $211.93 $287,412 - $357,313
1,686 New
1,686 $302,000
Q1 2021

May 17, 2021

SELL
$153.94 - $174.85 $720,901 - $818,822
-4,683 Closed
0 $0
Q4 2020

Feb 12, 2021

BUY
$101.87 - $151.79 $477,057 - $710,832
4,683 New
4,683 $711,000
Q1 2020

May 14, 2020

SELL
$79.39 - $115.35 $894,884 - $1.3 Million
-11,272 Closed
0 $0
Q4 2019

Feb 11, 2020

BUY
$78.31 - $95.34 $882,710 - $1.07 Million
11,272 New
11,272 $993,000

Others Institutions Holding UTHR

About UNITED THERAPEUTICS Corp


  • Ticker UTHR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,516,300
  • Market Cap $16.5B
  • Description
  • United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...
More about UTHR
Track This Portfolio

Track Wellington Management Group LLP Portfolio

Follow Wellington Management Group LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wellington Management Group LLP, based on Form 13F filings with the SEC.

News

Stay updated on Wellington Management Group LLP with notifications on news.